Patent intelligence · US
US 11208416
Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
Selective inhibitors of protein arginine methytransterase 5 (PRMT5)
Patent details — US 11208416
- Jurisdiction
- US
- Status
- granted
- Grant date
- Dec 28, 2021
- Expiration
- Dec 23, 2041
- Applicant
- Prelude Therapeutics, Incorporated
- Claims
- 37
- CPC classes
- A61K, A61K31/7064, A61P, A61P35/02
Quick answer
US 11208416 (Selective inhibitors of protein arginine methytransterase 5 (PRMT5)) is held by Prelude Therapeutics, Incorporated. Status: granted. Granted Dec 28, 2021. Expires Dec 23, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Prelude Therapeutics, Incorporated
- Grant date
- Expiration
- Claims
- 37
- CPC classes
- A61K, A61K31/7064, A61P, A61P35/02
More from Prelude Therapeutics, Incorporated
Related pharmaceutical patents in our USPTO index.
-
US 12414953
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)
granted -
US 12129262
CDK inhibitors and their use as pharmaceuticals
granted -
US 11939340
CDK inhibitors and their use as pharmaceuticals
granted -
US 11702423
BRM targeting compounds and associated methods of use
granted -
US 11685744
CDK inhibitors and their use as pharmaceuticals
granted -
US 11673893
CDK inhibitors and their use as pharmaceuticals
granted -
US 11622970
BCL-2 inhibitors and their use as pharmaceuticals
granted -
US 11524962
Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of protein arginine methyl transferase 5 (PRMT5)
granted
Frequently asked questions
What is US patent 11208416?
US 11208416 (Selective inhibitors of protein arginine methytransterase 5 (PRMT5)) is held by Prelude Therapeutics, Incorporated. Status: granted. Granted Dec 28, 2021. Expires Dec 23, 2041 (15 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11208416?
Prelude Therapeutics, Incorporated is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 16 pharmaceutical patents for this assignee.
When does US 11208416 expire?
Our index shows an expiration date of Dec 23, 2041 (15 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.